Free Trial

Omeros (OMER) Financials

Omeros logo
$3.32 +0.18 (+5.73%)
Closing price 04:00 PM Eastern
Extended Trading
$3.23 -0.09 (-2.83%)
As of 05:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Omeros

Annual Income Statements for Omeros

This table shows Omeros' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Net Income / (Loss) Attributable to Common Shareholders
-157 -118 47
Consolidated Net Income / (Loss)
-157 -118 47
Net Income / (Loss) Continuing Operations
-183 -175 -182
Total Pre-Tax Income
-183 -179 -182
Total Operating Income
-169 -165 -163
Total Gross Profit
0.00 0.00 0.00
Total Revenue
0.00 0.00 0.00
Total Cost of Revenue
0.00 0.00 0.00
Total Operating Expenses
169 165 163
Selling, General & Admin Expense
50 50 51
Research & Development Expense
120 115 113
Total Other Income / (Expense), net
-13 -15 -19
Interest Expense
25 31 23
Interest & Investment Income
11 16 4.06
Other Gains / (Losses), net
0.00 4.11 0.00
Net Income / (Loss) Discontinued Operations
26 57 229
Basic Earnings per Share
($2.70) ($1.88) $0.76
Weighted Average Basic Shares Outstanding
58.17M 62.74M 62.74M
Weighted Average Diluted Shares Outstanding
58.06M 57.94M 62.83M
Weighted Average Basic & Diluted Shares Outstanding
58.06M 57.94M 62.83M

Quarterly Income Statements for Omeros

This table shows Omeros' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
-31 -32 -56 -37 -9.07 -38 -37 -34 129 -17
Consolidated Net Income / (Loss)
-31 -32 -56 -37 -9.07 -38 -37 -34 129 -17
Net Income / (Loss) Continuing Operations
-37 -37 -65 -44 -39 -52 -44 -40 -46 -55
Total Pre-Tax Income
-37 -37 -65 -44 -43 -52 -44 -40 -46 -55
Total Operating Income
-36 -35 -59 -39 -40 -48 -41 -36 -40 -51
Total Operating Expenses
36 35 59 39 40 48 41 36 40 51
Selling, General & Admin Expense
12 11 14 12 11 16 11 11 14 12
Research & Development Expense
23 24 45 27 29 32 30 25 27 39
Total Other Income / (Expense), net
-0.88 -1.71 -5.97 -4.82 -3.63 -3.50 -3.40 -3.97 -5.91 -4.03
Interest Expense
3.18 4.05 9.22 8.23 7.06 7.92 7.93 7.93 7.90 4.93
Interest & Investment Income
2.30 2.35 3.25 3.42 3.43 4.41 4.54 3.96 1.99 0.91
Net Income / (Loss) Discontinued Operations
5.18 4.88 9.08 6.67 30 14 7.00 5.98 175 37
Basic Earnings per Share
($0.54) ($0.56) ($0.97) ($0.63) ($0.15) ($0.60) ($0.59) ($0.54) $2.06 ($0.28)
Weighted Average Basic Shares Outstanding
58.17M 57.95M 57.94M 58.80M 62.74M 62.86M 62.84M 62.83M 62.74M 62.73M
Weighted Average Diluted Shares Outstanding
58.06M 57.95M 57.95M 57.94M 57.94M 62.87M 62.86M 62.83M 62.83M 62.73M
Weighted Average Basic & Diluted Shares Outstanding
58.06M 57.95M 57.95M 57.94M 57.94M 62.87M 62.86M 62.83M 62.83M 62.73M

Annual Cash Flow Statements for Omeros

This table details how cash moves in and out of Omeros' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Net Change in Cash & Equivalents
-3.71 -3.90 -90
Net Cash From Operating Activities
-149 75 -86
Net Cash From Continuing Operating Activities
-149 75 -86
Net Income / (Loss) Continuing Operations
-157 -118 47
Consolidated Net Income / (Loss)
-157 -118 47
Depreciation Expense
0.95 0.92 0.95
Amortization Expense
1.70 1.85 1.83
Non-Cash Adjustments To Reconcile Net Income
15 -17 48
Changes in Operating Assets and Liabilities, net
-9.91 207 -185
Net Cash From Investing Activities
82 27 -128
Net Cash From Continuing Investing Activities
82 27 -128
Purchase of Property, Plant & Equipment
-0.17 -0.43 -0.11
Purchase of Investments
-987 -1,019 -429
Sale and/or Maturity of Investments
1,070 1,046 302
Net Cash From Financing Activities
63 -106 124
Net Cash From Continuing Financing Activities
63 -106 124
Repayment of Debt
-22 -100 0.00
Repurchase of Common Equity
-12 -4.65 0.00
Other Financing Activities, net
96 -1.56 124
Cash Interest Paid
36 30 19
Cash Income Taxes Paid
0.17 3.29 0.08

Quarterly Cash Flow Statements for Omeros

This table details how cash moves in and out of Omeros' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
1.88 -0.60 0.29 -5.27 -24 24 2.77 -7.18 -135 131
Net Cash From Operating Activities
-29 -32 -46 -42 -35 -33 -32 175 -25 -26
Net Cash From Continuing Operating Activities
-29 -32 -46 -42 -35 -33 -32 175 -25 -26
Net Income / (Loss) Continuing Operations
-31 -32 -56 -37 -9.07 -38 -37 -34 129 -17
Consolidated Net Income / (Loss)
-31 -32 -56 -37 -9.07 -38 -37 -34 129 -17
Depreciation Expense
0.30 0.24 0.21 0.20 0.21 0.20 0.33 0.19 0.16 0.32
Amortization Expense
0.50 0.52 -0.70 1.39 0.40 0.49 0.48 0.48 0.47 0.46
Non-Cash Adjustments To Reconcile Net Income
3.67 2.76 5.39 3.45 -22 -2.80 3.73 4.24 45 -17
Changes in Operating Assets and Liabilities, net
-2.10 -3.34 5.16 -9.63 -4.13 7.21 0.41 203 -199 7.17
Net Cash From Investing Activities
35 36 73 -62 116 57 35 -181 -108 33
Net Cash From Continuing Investing Activities
35 36 73 -62 116 57 35 -181 -108 33
Purchase of Property, Plant & Equipment
-0.03 -0.00 -0.08 -0.06 -0.12 -0.03 -0.28 0.00 -0.01 0.00
Purchase of Investments
-66 -296 -138 -488 -179 -177 -139 -524 -325 -0.40
Sale and/or Maturity of Investments
101 332 212 426 295 234 174 343 217 33
Net Cash From Financing Activities
-4.10 -4.58 -27 98 -105 -0.48 -0.26 -0.39 -0.65 125
Net Cash From Continuing Financing Activities
-4.10 -4.58 -27 98 -105 -0.48 -0.26 -0.39 -0.65 125
Repayment of Debt
-0.55 - -21 -0.13 -99 -0.43 0.11 -0.11 0.52 -0.16
Other Financing Activities, net
-3.54 -4.58 -5.83 110 -0.85 -0.06 -0.37 -0.28 -1.17 125
Cash Interest Paid
7.56 13 7.79 7.15 6.12 7.94 7.93 7.93 5.74 4.44
Cash Income Taxes Paid
0.27 0.04 - - -0.48 - - - - -

Annual Balance Sheets for Omeros

This table presents Omeros' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Total Assets
277 378 591
Total Current Assets
134 218 443
Cash & Equivalents
3.40 7.11 11
Short-Term Investments
87 165 184
Accounts Receivable
7.74 8.10 213
Prepaid Expenses
7.17 8.58 6.30
Other Current Assets
29 29 29
Plant, Property, & Equipment, net
2.68 1.95 1.49
Total Noncurrent Assets
140 158 146
Other Noncurrent Operating Assets
139 157 145
Other Noncurrent Nonoperating Assets
1.05 1.05 1.05
Total Liabilities & Shareholders' Equity
277 378 591
Total Liabilities
460 403 505
Total Current Liabilities
80 53 136
Short-Term Debt
21 0.00 94
Accounts Payable
5.91 7.71 5.99
Accrued Expenses
26 32 31
Other Current Liabilities
27 14 5.46
Total Noncurrent Liabilities
380 350 369
Long-Term Debt
167 213 221
Capital Lease Obligations
13 18 22
Other Noncurrent Operating Liabilities
200 119 126
Commitments & Contingencies
0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-183 -25 86
Total Preferred & Common Equity
-183 -25 86
Preferred Stock
0.00 0.00 0.00
Total Common Equity
-183 -25 86
Common Stock
728 729 721
Retained Earnings
-910 -754 -636

Quarterly Balance Sheets for Omeros

This table presents Omeros' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets
313 356 437 493 527 560 458
Total Current Assets
165 203 281 351 389 417 289
Cash & Equivalents
1.52 2.12 1.83 31 6.60 3.83 146
Short-Term Investments
122 157 229 280 335 368 75
Accounts Receivable
6.39 8.08 7.64 6.88 11 10 14
Prepaid Expenses
6.13 6.27 13 4.92 7.00 6.71 5.98
Other Current Assets
29 30 30 29 29 29 48
Plant, Property, & Equipment, net
1.94 2.03 1.80 1.72 1.75 1.34 1.85
Total Noncurrent Assets
146 151 155 140 137 142 167
Other Noncurrent Operating Assets
145 150 154 139 136 141 166
Other Noncurrent Nonoperating Assets
1.05 1.05 1.05 1.05 1.05 1.05 1.05
Total Liabilities & Shareholders' Equity
313 356 437 493 527 560 458
Total Liabilities
468 481 509 507 507 505 504
Total Current Liabilities
56 59 59 147 144 139 40
Accounts Payable
7.72 6.50 6.18 5.87 9.55 6.45 17
Accrued Expenses
23 28 28 35 30 31 18
Other Current Liabilities
25 25 19 12 9.46 7.37 4.41
Total Noncurrent Liabilities
412 421 450 360 363 366 464
Long-Term Debt
189 191 213 222 222 221 315
Capital Lease Obligations
14 16 17 19 - - -
Other Noncurrent Operating Liabilities
208 214 220 119 142 145 150
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-154 -125 -71 -14 21 55 -46
Total Preferred & Common Equity
-154 -125 -71 -14 21 55 -46
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-154 -125 -71 -14 21 55 -46
Common Stock
725 722 719 731 727 724 718
Retained Earnings
-879 -847 -791 -744 -707 -669 -764

Annual Metrics And Ratios for Omeros

This table displays calculated financial ratios and metrics derived from Omeros' official financial filings.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Growth Metrics
- - -
Revenue Growth
0.00% 0.00% 0.00%
EBITDA Growth
-3.00% -0.72% 5.82%
EBIT Growth
-2.87% -0.70% 5.89%
NOPAT Growth
-2.87% -0.70% 5.89%
Net Income Growth
-33.11% -348.46% -75.59%
EPS Growth
0.00% 0.00% 0.00%
Operating Cash Flow Growth
-299.13% 186.41% 21.18%
Free Cash Flow Firm Growth
-115.63% 148.40% 48.97%
Invested Capital Growth
-317.72% -85.31% 27.11%
Revenue Q/Q Growth
0.00% 0.00% 0.00%
EBITDA Q/Q Growth
2.52% 0.22% 1.60%
EBIT Q/Q Growth
2.37% 0.23% 1.66%
NOPAT Q/Q Growth
2.37% 0.23% 1.66%
Net Income Q/Q Growth
-16.57% -689.42% -76.21%
EPS Q/Q Growth
0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
3.78% -11.22% -9.04%
Free Cash Flow Firm Q/Q Growth
65.78% 199.03% 0.62%
Invested Capital Q/Q Growth
2.59% 213.15% 389.22%
Profitability Metrics
- - -
Gross Margin
0.00% 0.00% 0.00%
EBITDA Margin
0.00% 0.00% 0.00%
Operating Margin
0.00% 0.00% 0.00%
EBIT Margin
0.00% 0.00% 0.00%
Profit (Net Income) Margin
0.00% 0.00% 0.00%
Tax Burden Percent
85.87% 65.81% -26.05%
Interest Burden Percent
107.90% 108.81% 111.41%
Effective Tax Rate
0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00%
Return on Equity (ROE)
151.08% -388.17% 86.63%
Cash Return on Invested Capital (CROIC)
0.00% 60.45% -80.17%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00%
Return on Assets (ROA)
0.00% 0.00% 0.00%
Return on Common Equity (ROCE)
151.08% -388.17% 86.63%
Return on Equity Simple (ROE_SIMPLE)
85.87% 471.57% 55.34%
Net Operating Profit after Tax (NOPAT)
-118 -115 -114
NOPAT Margin
0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)
45.57% 2.64% -108.99%
Return On Investment Capital (ROIC_SIMPLE)
-642.52% -55.82% -27.01%
Cost of Revenue to Revenue
0.00% 0.00% 0.00%
SG&A Expenses to Revenue
0.00% 0.00% 0.00%
R&D to Revenue
0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)
-169 -165 -163
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-167 -162 -161
Valuation Ratios
- - -
Price to Book Value (P/BV)
0.00 0.00 1.65
Price to Tangible Book Value (P/TBV)
0.00 0.00 1.65
Price to Revenue (P/Rev)
0.00 0.00 0.00
Price to Earnings (P/E)
0.00 0.00 2.99
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 33.45%
Enterprise Value to Invested Capital (EV/IC)
0.00 7.93 1.25
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 3.55 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 3.36 0.00
Leverage & Solvency
- - -
Debt to Equity
-1.10 -9.26 3.94
Long-Term Debt to Equity
-0.99 -9.26 2.84
Financial Leverage
-0.81 3.30 2.71
Leverage Ratio
-3.16 15.97 9.23
Compound Leverage Factor
-3.41 17.37 10.28
Debt to Total Capital
1,090.29% 112.11% 79.76%
Short-Term Debt to Total Capital
113.88% 0.00% 22.29%
Long-Term Debt to Total Capital
976.40% 112.11% 57.47%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00%
Common Equity to Total Capital
-990.29% -12.11% 20.24%
Debt to EBITDA
-1.21 -1.43 -2.10
Net Debt to EBITDA
-0.67 -0.37 -0.89
Long-Term Debt to EBITDA
-1.08 -1.43 -1.52
Debt to NOPAT
-1.70 -2.01 -2.95
Net Debt to NOPAT
-0.94 -0.52 -1.25
Long-Term Debt to NOPAT
-1.52 -2.01 -2.13
Altman Z-Score
-5.63 -3.40 -1.63
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00%
Liquidity Ratios
- - -
Current Ratio
1.69 4.09 3.25
Quick Ratio
1.23 3.38 2.99
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
-12 79 -163
Operating Cash Flow to CapEx
-90,183.64% 17,541.31% -76,533.63%
Free Cash Flow to Firm to Interest Expense
-0.50 2.56 -7.17
Operating Cash Flow to Interest Expense
-6.03 2.42 -3.81
Operating Cash Flow Less CapEx to Interest Expense
-6.04 2.41 -3.81
Efficiency Ratios
- - -
Asset Turnover
0.00 0.00 0.00
Accounts Receivable Turnover
0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 0.00
Capital & Investment Metrics
- - -
Invested Capital
-73 33 227
Invested Capital Turnover
0.00 0.00 0.00
Increase / (Decrease) in Invested Capital
-106 -194 49
Enterprise Value (EV)
683 265 285
Market Capitalization
573 206 142
Book Value per Share
($3.15) ($0.40) $1.37
Tangible Book Value per Share
($3.15) ($0.40) $1.37
Total Capital
18 206 423
Total Debt
201 231 338
Total Long-Term Debt
180 231 243
Net Debt
111 59 143
Capital Expenditures (CapEx)
0.17 0.43 0.11
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-15 -7.27 206
Debt-free Net Working Capital (DFNWC)
76 165 401
Net Working Capital (NWC)
55 165 307
Net Nonoperating Expense (NNE)
38 2.64 -162
Net Nonoperating Obligations (NNO)
110 58 142
Total Depreciation and Amortization (D&A)
2.65 2.77 2.78
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00%
Net Working Capital to Revenue
0.00% 0.00% 0.00%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
($2.70) ($1.88) $0.76
Adjusted Weighted Average Basic Shares Outstanding
58.17M 62.74M 62.74M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.76
Adjusted Weighted Average Diluted Shares Outstanding
58.06M 57.94M 62.74M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
58.06M 57.94M 62.83M
Normalized Net Operating Profit after Tax (NOPAT)
-118 -115 -114
Normalized NOPAT Margin
0.00% 0.00% 0.00%
Pre Tax Income Margin
0.00% 0.00% 0.00%
Debt Service Ratios
- - -
EBIT to Interest Expense
-6.86 -5.33 -7.20
NOPAT to Interest Expense
-4.80 -3.73 -5.04
EBIT Less CapEx to Interest Expense
-6.87 -5.35 -7.20
NOPAT Less CapEx to Interest Expense
-4.81 -3.75 -5.04
Payout Ratios
- - -
Dividend Payout Ratio
0.00% 0.00% 0.00%
Augmented Payout Ratio
-7.56% -3.95% 0.00%

Quarterly Metrics And Ratios for Omeros

This table displays calculated financial ratios and metrics derived from Omeros' official financial filings.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - -
Revenue Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth
10.98% 26.99% -48.81% -6.83% 0.89% 5.04% -8.95% -2.12% 6.21% -27.91%
EBIT Growth
10.32% 26.47% -44.64% -9.30% 0.93% 5.15% -9.24% -1.90% 6.41% -27.46%
NOPAT Growth
10.32% 26.47% -44.64% -9.30% 0.93% 5.15% -9.24% -1.90% 6.41% -27.46%
Net Income Growth
-245.81% 14.62% -50.27% -10.34% -107.04% -116.26% -20.89% -2.09% -54.13% 23.11%
EPS Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth
16.78% 1.80% -42.19% -123.94% -37.20% -23.48% -66.12% 1,248.81% -39.35% -11.74%
Free Cash Flow Firm Growth
-51.14% 2,770.61% -77.37% -73.23% 316.93% 102.54% 170.06% 172.01% 66.35% -158.04%
Invested Capital Growth
-317.72% -799.93% -1,289.32% -3,825.01% -85.31% -77.05% -103.53% -101.03% 27.11% 4,306.97%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
-0.59% 41.91% -59.31% 4.38% 17.50% -18.41% -14.37% 11.28% 20.96% -35.85%
EBIT Q/Q Growth
-0.71% 40.15% -51.55% 1.84% 17.42% -17.74% -14.52% 11.03% 20.93% -35.60%
NOPAT Q/Q Growth
-0.71% 40.15% -51.55% 1.84% 17.42% -17.74% -14.52% 11.03% 20.93% -35.60%
Net Income Q/Q Growth
2.71% 42.49% -50.71% -310.06% 75.98% -1.22% -10.66% -126.18% 837.47% 43.41%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
9.60% 30.29% -10.06% -19.97% -6.67% -0.95% -118.53% 787.65% 4.00% -35.80%
Free Cash Flow Firm Q/Q Growth
34.06% 98.27% -19.87% -77.06% 7,776.04% -98.44% -5.21% 285.89% 7.85% 56.85%
Invested Capital Q/Q Growth
2.59% 3.68% -15.46% -300.99% 213.15% 291.18% -226.18% -100.75% 389.22% -70.59%
Profitability Metrics
- - - - - - - - - -
Gross Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent
85.82% 86.85% 86.05% 84.80% 20.89% 73.08% 84.20% 84.93% -279.56% 31.86%
Interest Burden Percent
102.47% 104.82% 110.09% 112.34% 109.14% 107.27% 108.30% 111.12% 114.72% 107.93%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
151.08% 160.03% 269.09% 1,479.94% -388.17% -66.33% -660.79% 186.87% 86.63% -129.00%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 60.45% -278.59% 0.00% 0.00% -80.17% -352.55%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)
151.08% 160.03% 269.09% 1,479.94% -388.17% -66.33% -660.79% 186.87% 86.63% -129.00%
Return on Equity Simple (ROE_SIMPLE)
0.00% 87.26% 112.40% 170.05% 0.00% -143.26% 196.40% 85.06% 0.00% -430.33%
Net Operating Profit after Tax (NOPAT)
-25 -25 -41 -27 -28 -34 -29 -25 -28 -36
NOPAT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)
7.60% 14.31% 139.55% -37.58% -18.75% 6.89% 10.53% 15.27% -105.65% -10.20%
Return On Investment Capital (ROIC_SIMPLE)
-135.37% - - - -13.49% - - - -6.64% -
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)
-36 -35 -59 -39 -40 -48 -41 -36 -40 -51
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-35 -35 -60 -37 -39 -47 -40 -35 -40 -50
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.00 0.00 16.66 5.32 1.65 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 16.66 5.32 1.65 0.00
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 9.18 8.48 6.25 2.99 0.99
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 10.89% 11.79% 15.99% 33.45% 100.86%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 7.93 19.61 0.00 0.00 1.25 6.27
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 3.55 2.49 3.50 2.29 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 3.36 0.00 6.83 4.50 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
-1.10 -1.32 -1.66 -3.30 -9.26 -24.08 15.42 5.75 3.94 -6.80
Long-Term Debt to Equity
-0.99 -1.32 -1.66 -3.23 -9.26 -17.28 10.80 4.03 2.84 -6.80
Financial Leverage
-0.81 -0.62 -0.20 3.20 3.30 -1.95 -13.50 2.28 2.71 -1.15
Leverage Ratio
-3.16 -4.80 -8.49 -60.86 15.97 -15.77 -71.61 18.58 9.23 -1.88
Compound Leverage Factor
-3.23 -5.03 -9.35 -68.37 17.43 -16.92 -77.55 20.65 10.59 -2.03
Debt to Total Capital
1,090.29% 411.28% 251.16% 143.43% 112.11% 104.33% 93.91% 85.18% 79.76% 117.25%
Short-Term Debt to Total Capital
113.88% 0.00% 0.00% 3.25% 0.00% 29.47% 28.13% 25.51% 22.29% 0.00%
Long-Term Debt to Total Capital
976.40% 411.28% 251.16% 140.18% 112.11% 74.86% 65.78% 59.67% 57.47% 117.25%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
-990.29% -311.28% -151.16% -43.43% -12.11% -4.33% 6.09% 14.82% 20.24% -17.25%
Debt to EBITDA
-1.21 -1.19 -1.13 -1.44 -1.43 -2.07 -1.92 -1.96 -2.10 -1.93
Net Debt to EBITDA
-0.67 -0.47 -0.26 -0.03 -0.37 -0.16 0.15 0.34 -0.89 -0.58
Long-Term Debt to EBITDA
-1.08 -1.19 -1.13 -1.40 -1.43 -1.49 -1.35 -1.37 -1.52 -1.93
Debt to NOPAT
-1.70 -1.68 -1.59 -2.00 -2.01 -2.91 -2.70 -2.75 -2.95 -2.71
Net Debt to NOPAT
-0.94 -0.66 -0.37 -0.04 -0.52 -0.22 0.21 0.48 -1.25 -0.81
Long-Term Debt to NOPAT
-1.52 -1.68 -1.59 -1.96 -2.01 -2.09 -1.89 -1.93 -2.13 -2.71
Altman Z-Score
-4.04 -3.59 -3.10 -1.96 -2.31 -1.72 -1.17 -0.94 -0.94 -1.82
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.69 2.97 3.41 4.76 4.09 2.39 2.71 3.00 3.25 7.30
Quick Ratio
1.23 2.33 2.81 4.03 3.38 2.16 2.46 2.74 2.99 5.94
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
81 61 31 38 166 2.11 135 142 -77 -83
Operating Cash Flow to CapEx
-111,461.54% -3,205,800.00% -57,481.25% -72,034.48% -29,512.71% -98,930.30% -11,760.36% 0.00% -195,246.15% 0.00%
Free Cash Flow to Firm to Interest Expense
25.56 14.95 3.31 4.63 23.53 0.27 17.02 17.95 -9.69 -16.85
Operating Cash Flow to Interest Expense
-9.12 -7.91 -4.99 -5.08 -4.93 -4.12 -4.08 22.00 -3.21 -5.36
Operating Cash Flow Less CapEx to Interest Expense
-9.13 -7.91 -5.00 -5.08 -4.95 -4.13 -4.11 22.00 -3.21 -5.36
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
-73 -75 -78 -67 33 11 -5.58 -1.71 227 46
Invested Capital Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital
-106 -85 -72 -65 -194 -36 -164 -167 49 48
Enterprise Value (EV)
683 311 283 222 265 209 317 237 285 291
Market Capitalization
573 230 235 217 206 184 342 292 142 198
Book Value per Share
($3.15) ($2.66) ($2.15) ($1.13) ($0.40) ($0.22) $0.33 $0.87 $1.37 ($0.74)
Tangible Book Value per Share
($3.15) ($2.66) ($2.15) ($1.13) ($0.40) ($0.22) $0.33 $0.87 $1.37 ($0.74)
Total Capital
18 50 82 164 206 322 337 371 423 269
Total Debt
201 204 207 236 231 336 316 316 338 315
Total Long-Term Debt
180 204 207 230 231 241 222 221 243 315
Net Debt
111 81 48 5.23 59 26 -25 -56 143 94
Capital Expenditures (CapEx)
0.03 0.00 0.08 0.06 0.12 0.03 0.28 0.00 0.01 -0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-15 -14 -15 -3.09 -7.27 -11 -1.53 1.04 206 28
Debt-free Net Working Capital (DFNWC)
76 109 143 227 165 299 340 372 401 249
Net Working Capital (NWC)
55 109 143 222 165 204 245 278 307 249
Net Nonoperating Expense (NNE)
6.40 7.45 15 9.86 -19 4.04 8.66 8.70 -157 -18
Net Nonoperating Obligations (NNO)
110 79 47 4.17 58 25 -26 -57 142 93
Total Depreciation and Amortization (D&A)
0.80 0.75 -0.50 1.59 0.61 0.69 0.81 0.66 0.63 0.78
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
($0.54) ($0.56) ($0.97) ($0.63) ($0.15) ($0.60) ($0.59) ($0.54) $2.06 ($0.28)
Adjusted Weighted Average Basic Shares Outstanding
58.17M 57.95M 57.94M 58.80M 62.74M 62.86M 62.84M 62.83M 62.74M 62.73M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 ($0.59) ($0.54) $0.00 ($0.28)
Adjusted Weighted Average Diluted Shares Outstanding
58.06M 57.95M 57.95M 57.94M 57.94M 62.87M 62.84M 62.83M 62.83M 62.73M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
58.06M 57.95M 57.95M 57.94M 57.94M 62.87M 62.86M 62.83M 62.83M 62.73M
Normalized Net Operating Profit after Tax (NOPAT)
-25 -25 -41 -27 -28 -34 -29 -25 -28 -36
Normalized NOPAT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
-11.22 -8.74 -6.42 -4.74 -5.63 -6.08 -5.16 -4.50 -5.08 -10.29
NOPAT to Interest Expense
-7.86 -6.12 -4.49 -3.32 -3.94 -4.26 -3.61 -3.15 -3.56 -7.21
EBIT Less CapEx to Interest Expense
-11.23 -8.74 -6.43 -4.75 -5.65 -6.09 -5.19 -4.50 -5.08 -10.29
NOPAT Less CapEx to Interest Expense
-7.87 -6.12 -4.50 -3.33 -3.96 -4.26 -3.64 -3.15 -3.56 -7.20
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-7.56% -12.27% -11.79% -13.61% -3.95% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Omeros' Financials

When does Omeros's financial year end?

According to the most recent income statement we have on file, Omeros' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Omeros' net income changed over the last 2 years?

Omeros' net income appears to be on an upward trend, with a most recent value of -$156.82 million in 2024, falling from $47.42 million in 2022. The previous period was -$117.81 million in 2023. See where experts think Omeros is headed by visiting Omeros' forecast page.

What is Omeros's operating income?
Omeros's total operating income in 2024 was -$169.26 million, based on the following breakdown:
  • Total Gross Profit: $0.00
  • Total Operating Expenses: $169.26 million
How has Omeros revenue changed over the last 2 years?

Over the last 2 years, Omeros' total revenue changed from $0.00 in 2022 to $0.00 in 2024, a change of 0.0%.

How much debt does Omeros have?

Omeros' total liabilities were at $459.69 million at the end of 2024, a 14.0% increase from 2023, and a 9.0% decrease since 2022.

How much cash does Omeros have?

In the past 2 years, Omeros' cash and equivalents has ranged from $3.40 million in 2024 to $11.01 million in 2022, and is currently $3.40 million as of their latest financial filing in 2024.

How has Omeros' book value per share changed over the last 2 years?

Over the last 2 years, Omeros' book value per share changed from 1.37 in 2022 to -3.15 in 2024, a change of -330.7%.



This page (NASDAQ:OMER) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners